Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01014598
Show Display Options
Rank Status Study
1 Recruiting Cisplatin in Treating Patients With Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Adult Soft Tissue Sarcoma;   Stage IV Non-small Cell Lung Cancer
Intervention: Drug: cisplatin

Indicates status has not been verified in more than two years